Trevi Therapeutics
1 follower
‌
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.
Industries
Headquarters
Employees
Links
Org chart
Jennifer Good
Co-Founder, President & CEO
Jennifer Good
Collapse
Thomas Sciascia
Co-Founder, Chief Science Officer
Lisa Delfini
CFO
David Clark
Chief Medical Officer
Farrell Simon
Chief Commercial Officer
Katherine Takaki
VP, Global Regulatory Affairs
Katie McManus
Senior Manager, Marketing & Communications
Paula Buckley
VP, Clinical Operations
Pam Nieves
Associate Director, Quality Assurance & Compliance
Similar companies
Mississippi State University
1 follower
SOPHiA GENETICS
4 followers
Manifold Bio
2 followers
Thermo Fisher Scientific
149 followers
Alexion Pharmaceuticals
33 followers
HotSpot Therapeutics
1 follower
Allakos
1 follower
Kriya Therapeutics
1 follower
EasyLLama
1 follower
The University of Texas at Dallas
8 followers
Houston ISD
7 followers
Discover companies